Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men age. BPH is very common, affecting over 700 million men worldwide. More than 40% of men in their 50s and more than 70% of men in their 60s have BPH.1 While BPH is a benign condition and unrelated to prostate cancer, it can greatly affect a man's quality of life.
A wide variety of treatments are available for men with BPH, including medication, minimally invasive therapies, and surgery. You and your doctor will consider several factors when you evaluate these choices.
The International Prostate Symptom Score (IPSS) is a common method for screening and diagnosing benign prostatic hyperplasia (BPH). The survey asks seven urinary symptom questions and one quality of life question to help determine the severity of your BPH.
Get answers to more than 20 frequently asked questions about The UroLift System.
Source Information
1. Berry, et al., Journal of Urology 1984; U.S. Census Bureau - International Database by Region, Age and Year
Indicated for the treatment of symptoms of an enlarged prostate up to 100cc in men 45 years or older. As with any medical procedure, individual results may vary. Most common side effects are temporary and include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and /or the inability to control the urge (Roehrborn, J Urology 2013). Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention. Speak with your doctor to determine if you may be a candidate.
Teleflex, the Teleflex logo, UroLift, the UroLift logo, BPH Advisor, MyBPH Report, and UroLift ATC are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the US and/or other countries.
IDA Business and Technology Park
Dublin Road, Athlone
Co Westmeath
© 2025 Teleflex Inc. All rights reserved. | Terms of Use | Internet Privacy Policy | Patient Safety | Imprint | Compliance